Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzyme Catalysis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104651292A reveals high-purity S-CHBE synthesis via recombinant E. coli. Achieves 100% conversion and 99.4% ee for scalable pharmaceutical intermediates.
Patent CN117165543A reveals a high-yield biocatalytic route for furfuryl alcohol. Discover cost-effective manufacturing and supply chain advantages for fine chemical intermediates.
Patent CN116103255A details engineered KdAKR mutants for high-yield synthesis of tert-butyl 6-chloro-(3R,5S)-dihydroxyhexanoate, offering superior stereoselectivity and thermal stability for statin production.
Advanced recombinant E. coli strain for D-pantoic acid production from valine. Offers cost-effective, scalable biosynthesis for reliable vitamin B5 precursor supply chains.
Patent CN109576234B reveals a highly active V77A mutant enzyme enabling efficient biosynthesis of hydroxylated amino acids, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN108486075A details a mutant enzyme for statin side chains, offering enhanced catalytic efficiency and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN115725668B reveals high-purity L-vinylglycine via multi-enzyme cascade. Offers supply chain reliability and cost reduction in agrochemical intermediate manufacturing.
Patent CN116396950A reveals a novel carboxylesterase mutant for efficient (R)-3-cyclohexene-1-carboxylic acid production, offering superior stereoselectivity and scalable biocatalysis for API intermediates.
Patent CN112143688A reveals a novel recombinant E. coli strain for high-purity (S)-CHBE production, offering significant cost reduction in API manufacturing.
Patent CN117737149A details enzymatic synthesis for high-purity S-vitronectin. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN117568302A reveals high-yield 2'-FL production. Cost-effective biocatalysis for infant nutrition supply chains.
Patent CN101469318B details enzymatic synthesis achieving 100 percent e.e. purity. This report analyzes cost reduction in chiral chemical manufacturing and supply chain reliability for global buyers.
Patent CN118147114A reveals beta-glucosidase mutant for phloretin. Enables cost reduction in flavonoid manufacturing and reliable supply chain scalability.
Patent CN119120437A reveals high-efficiency enzyme mutants for tyrosine derivatives. Achieves 160g/L concentration and 99.9% purity, offering significant supply chain and cost advantages for manufacturers.
Patent CN116949024B reveals mutant enzyme boosting conversion. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN118421578A reveals high-efficiency carbonyl reductase for Montelukast intermediate. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN109136298B reveals a dual-enzyme membrane separation process for D-amino acids, offering >99.9% e.e. and scalable green manufacturing solutions.
Patent CN1786179A details a novel dual-enzyme biocatalytic route for S-(+)-2,2-dimethylcyclopropylcarboxamide, offering superior stereocontrol and reduced environmental impact for cilastatin synthesis.
Novel multi-enzyme cascade method for p-coumaric acid production offers high purity and cost efficiency for pharmaceutical and food industries.
Patent CN110452942B reveals a cost-effective immobilized enzyme method for D-ribulose, offering significant supply chain stability and reduced manufacturing costs for pharmaceutical intermediates.